Literature DB >> 28624699

Toll-like receptor 2 rs4696480 polymorphism and risk of oral cancer and oral potentially malignant disorder.

Camila de Barros Gallo1, Xabier Marichalar-Mendia2, Amaia Setien-Olarra3, Amelia Acha-Sagredo3, Naiara Garcia Bediaga3, Maria Luisa Gainza-Cirauqui4, Norberto Nobuo Sugaya1, Jose Manuel Aguirre-Urizar3.   

Abstract

OBJECTIVES: The aim of this study was to identify the possible association between TLR polymorphisms and an increased risk of developing head and neck cancer, including oral (OSCC) and laryngeal squamous cell carcinoma (LSCC), and oral potentially malignant disorders, such as oral lichenoid disease (OLD), including oral lichen planus (OLP) and oral lichenoid lesions (OLL).
DESIGN: This case-control study included 40 OSCC, 35 LSCC, 175 OLD (129 OLP and 46 OLL) patients and 89 healthy controls, all of them from the Basque Country, Spain. Genetic polymorphisms in TLR1, TLR2, TLR4, TLR6, TLR9, and TLR10 were genotyped by TaqMan® assays or pyrosequencing.
RESULTS: The chi-square analysis showed that the variant A of the SNP TLR2-rs4696480 polymorphism significantly increased the risk of OSCC (p=0.03) and OLL (p=0.02).
CONCLUSIONS: The TLR2-rs4696480 polymorphism may be relevant to OSCC and OLL susceptibility in this population encouraging further studies on the TLR2 pathway and its possible association with this group of oral potentially malignant disorders and oral cancer. This may also prove the use of TLR polymorphisms as risk markers for oral and laryngeal cancer.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Oral cancer; Oral lichen planus; Precancerous conditions; Single nucleotide polymorphisms; Toll-like receptors

Mesh:

Substances:

Year:  2017        PMID: 28624699     DOI: 10.1016/j.archoralbio.2017.06.003

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  5 in total

1.  TLR2 deficiency enhances susceptibility to oral carcinogenesis by promoting an inflammatory environment.

Authors:  Bang Li; De-Qiang Hou; Shuang-Bo Xu; Jia-Yi Zhang; Li-Fang Zhu; Qiong Wang; Lu Pan; Miao Yu; Wei-Li Shen; Wei-Wen Zhu; Wei Zhang; Ying-Ming Sun; Lai-Kui Liu
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

Review 2.  Clinical update on head and neck cancer: molecular biology and ongoing challenges.

Authors:  Elham Alsahafi; Katheryn Begg; Ivano Amelio; Nina Raulf; Philippe Lucarelli; Thomas Sauter; Mahvash Tavassoli
Journal:  Cell Death Dis       Date:  2019-07-15       Impact factor: 8.469

Review 3.  Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification.

Authors:  Vince Kornél Grolmusz; Anikó Bozsik; János Papp; Attila Patócs
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

4.  -196 to -174del, rs4696480, rs3804099 polymorphisms of Toll-like receptor 2 gene impact the susceptibility of cancers: evidence from 37053 subjects.

Authors:  Sheng-Lin Gao; Yi-Ding Chen; Chuang Yue; Jiasheng Chen; Li-Feng Zhang; Si-Min Wang; Li Zuo
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

5.  TLR4 Expression in Ex-Lichenoid Lesions-Oral Squamous Cell Carcinomas and Its Surrounding Epithelium: The Role of Tumor Inflammatory Microenvironment.

Authors:  Fernanda Visioli; Julia Silveira Nunes; Maria Carmela Pedicillo; Rosalia Leonardi; Angela Santoro; Gian Franco Zannoni; Gabriella Aquino; Margherita Cerrone; Monica Cantile; Nunzia Simona Losito; Vito Rodolico; Giuseppina Campisi; Giuseppe Colella; Ilenia Sara De Stefano; Maria Antonietta Ramunno; Cristina Pizzulli; Marco Visconti; Lorenzo Lo Muzio; Giuseppe Pannone
Journal:  Biomolecules       Date:  2022-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.